Vanguard Group
EYPT icon

Vanguard Group’s EyePoint Inc EYPT Stock Holding History

Vanguard Group’s Portfolio EYPT Stock Details EYPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$88.1M Buy
4,822,139
+1,027,623
+27% +$14.6M ﹤0.01% 1922
2025
Q3 		$54M Sell
3,794,516
-8,130
-0.2% -$93.6K ﹤0.01% 2114
2025
Q2 		$35.8M Sell
3,802,646
-31,722
-0.8% -$219K ﹤0.01% 2278
2025
Q1 		$20.8M Buy
3,834,368
+31,141
+0.8% +$218K ﹤0.01% 2489
2024
Q4 		$28.3M Buy
3,803,227
+755,045
+25% +$7.03M ﹤0.01% 2416
2024
Q3 		$24.4M Buy
3,048,182
+273,728
+10% +$2.4M ﹤0.01% 2500
2024
Q2 		$24.1M Buy
2,774,454
+378,226
+16% +$5.28M ﹤0.01% 2472
2024
Q1 		$49.5M Buy
2,396,228
+362,168
+18% +$8.97M ﹤0.01% 2170
2023
Q4 		$47M Buy
2,034,060
+593,336
+41% +$6.63M ﹤0.01% 2212
2023
Q3 		$11.5M Buy
1,440,724
+37,486
+3% +$411K ﹤0.01% 2809
2023
Q2 		$12.2M Buy
1,403,238
+4,205
+0.3% +$25.7K ﹤0.01% 2826
2023
Q1 		$4.11M Buy
1,399,033
+3,447
+0.2% +$12.3K ﹤0.01% 3395
2022
Q4 		$4.88M Sell
1,395,586
-2,902
-0.2% -$12.8K ﹤0.01% 3321
2022
Q3 		$11.1M Buy
1,398,488
+43,170
+3% +$401K ﹤0.01% 2914
2022
Q2 		$10.7M Buy
1,355,318
+122,517
+10% +$1.23M ﹤0.01% 2959
2022
Q1 		$15M Buy
1,232,801
+43,831
+4% +$481K ﹤0.01% 2932
2021
Q4 		$14.6M Buy
1,188,970
+96,664
+9% +$1.3M ﹤0.01% 3016
2021
Q3 		$11.4M Buy
1,092,306
+5,977
+0.6% +$57K ﹤0.01% 3162
2021
Q2 		$9.77M Buy
1,086,329
+181,890
+20% +$1.75M ﹤0.01% 3211
2021
Q1 		$9.19M Buy
904,439
+582,736
+181% +$6.56M ﹤0.01% 3193
2020
Q4 		$2.12M Sell
321,703
-27
-0% -$126 ﹤0.01% 3646
2020
Q3 		$1.67M Sell
321,730
-8,046
-2% -$50.4K ﹤0.01% 3536
2020
Q2 		$2.5M Sell
329,776
-20,467
-6% -$176K ﹤0.01% 3368
2020
Q1 		$3.57M Buy
350,243
+50,369
+17% +$747K ﹤0.01% 3115
2019
Q4 		$4.65M Sell
299,874
-914
-0.3% -$16.3K ﹤0.01% 3195
2019
Q3 		$5.44M Buy
300,788
+32,459
+12% +$503K ﹤0.01% 3109
2019
Q2 		$4.4M Sell
268,329
-10,477
-4% -$176K ﹤0.01% 3211
2019
Q1 		$4.99M Buy
278,806
+26,024
+10% +$618K ﹤0.01% 3141
2018
Q4 		$4.78M Buy
252,782
+72,911
+41% +$1.77M ﹤0.01% 3107
2018
Q3 		$6.42M Buy
179,871
+4,736
+3% +$109K ﹤0.01% 3139
2018
Q2 		$3.64M Buy
175,135
+7,542
+5% +$148K ﹤0.01% 3316
2018
Q1 		$2.04M Buy
167,593
+10,797
+7% +$122K ﹤0.01% 3457
2017
Q4 		$1.69M Buy
156,796
+44,589
+40% +$537K ﹤0.01% 3475
2017
Q3 		$1.35M Buy
112,207
+2,315
+2% +$29.6K ﹤0.01% 3512
2017
Q2 		$1.88M Sell
109,892
-4,688
-4% -$89.2K ﹤0.01% 3400
2017
Q1 		$1.97M Buy
114,580
+3,889
+4% +$69.1K ﹤0.01% 3386
2016
Q4 		$1.89M Buy
110,691
+12,579
+13% +$255K ﹤0.01% 3378
2016
Q3 		$2.95M Buy
98,112
+2,738
+3% +$99.3K ﹤0.01% 3236
2016
Q2 		$2.7M Buy
95,374
+1,287
+1% +$39.5K ﹤0.01% 3255
2016
Q1 		$2.52M Buy
94,087
+18,509
+24% +$585K ﹤0.01% 3293
2015
Q4 		$3.64M Buy
75,578
+2,110
+3% +$82.2K ﹤0.01% 3130
2015
Q3 		$2.68M Buy
73,468
+1,523
+2% +$59.8K ﹤0.01% 3242
2015
Q2 		$2.71M Buy
71,945
+1,210
+2% +$48.1K ﹤0.01% 3294
2015
Q1 		$2.79M Buy
70,735
+4,509
+7% +$189K ﹤0.01% 3272
2014
Q4 		$2.72M Buy
66,226
+2,018
+3% +$80.8K ﹤0.01% 3166
2014
Q3 		$2.84M Buy
64,208
+2,833
+5% +$128K ﹤0.01% 3120
2014
Q2 		$2.66M Hold
61,375
– – ﹤0.01% 3132
2014
Q1 		$2.52M Buy
61,375
+18,185
+42% +$800K ﹤0.01% 3119
2013
Q4 		$1.72M Buy
43,190
+6,054
+16% +$196K ﹤0.01% 3248
2013
Q3 		$1.53M Buy
37,136
+3,091
+9% +$114K ﹤0.01% 3241
2013
Q2 		$1.32M Buy
+34,045
New +$991K ﹤0.01% 3219

Other funds holding EYPT

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group's EYPT Position: Q4 2025 in Review

Vanguard Group increased its EyePoint Inc (EYPT) stake by 27% in Q4 2025, buying an estimated $14.6M and bringing the position to 4,822,139 shares worth $88.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1922.

Vanguard Group first reported a position in EYPT in Q2 2013 and has held it in 51 quarters since. 166 funds tracked by Wall St. Rank hold EYPT as of Q4 2025.

  • Vanguard Group held 4,822,139 shares of EyePoint Inc worth $88.1M as of Q4 2025.
  • Vanguard Group bought 1,027,623 EyePoint Inc shares in Q4 2025, an estimated $14.6M.
  • EyePoint Inc made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1922 holding.
  • Vanguard Group first reported a position in EyePoint Inc in Q2 2013 and has held it in 51 quarters since.
  • 166 funds tracked by Wall St. Rank held EyePoint Inc as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.